IP Library › Granted Patent US 7,335,668
Granted Patent B2
US 7,335,668 · App. 10/479,798 · Granted Feb 26, 2008

Pharmaceutical composition for therapy of interstitial cystitis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,335,668
App. No.
10/479,798
Granted
Feb 26, 2008
Kind
B2
Abstract

A depressant of capsaicin-sensitive sensory nerve, containing quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a salt thereof as an active ingredient, specifically a therapeutic drug of interstitial cystitis, hypersensitive disorder of the lower urinary tract, and/or abacterial prostatitis.

Claims (2)

1. A method of depressing capsaicin-sensitive sensory nerves, comprising administering to a patient a therapeutically effective amount of quinuclidin-3′-yl 1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof.

2. The method according to claim 1 , in which an oral preparation is administered.

Assignments (2)
CHANGE OF NAME Recorded Nov 16, 2005
From: YAMANOUCHI PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016784/0361 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2003
From: IKEDA, KEN; TAKEUCHI, MAKOTO
To: YAMANOUCHI PHARMACEUTICAL CO., LTD.
Reel/Frame 015280/0928 →